1. Home
  2. FGBI vs RCEL Comparison

FGBI vs RCEL Comparison

Compare FGBI & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGBI
  • RCEL
  • Stock Information
  • Founded
  • FGBI 1934
  • RCEL N/A
  • Country
  • FGBI United States
  • RCEL United States
  • Employees
  • FGBI N/A
  • RCEL N/A
  • Industry
  • FGBI Savings Institutions
  • RCEL Medical/Dental Instruments
  • Sector
  • FGBI Finance
  • RCEL Health Care
  • Exchange
  • FGBI Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • FGBI 135.7M
  • RCEL 158.1M
  • IPO Year
  • FGBI N/A
  • RCEL N/A
  • Fundamental
  • Price
  • FGBI $8.10
  • RCEL $5.16
  • Analyst Decision
  • FGBI
  • RCEL Strong Buy
  • Analyst Count
  • FGBI 0
  • RCEL 4
  • Target Price
  • FGBI N/A
  • RCEL $16.50
  • AVG Volume (30 Days)
  • FGBI 6.0K
  • RCEL 271.4K
  • Earning Date
  • FGBI 08-12-2025
  • RCEL 08-07-2025
  • Dividend Yield
  • FGBI 0.50%
  • RCEL N/A
  • EPS Growth
  • FGBI N/A
  • RCEL N/A
  • EPS
  • FGBI 0.13
  • RCEL N/A
  • Revenue
  • FGBI $81,247,000.00
  • RCEL $71,661,000.00
  • Revenue This Year
  • FGBI N/A
  • RCEL $57.16
  • Revenue Next Year
  • FGBI $3.38
  • RCEL $36.69
  • P/E Ratio
  • FGBI $61.27
  • RCEL N/A
  • Revenue Growth
  • FGBI N/A
  • RCEL 41.35
  • 52 Week Low
  • FGBI $6.56
  • RCEL $4.71
  • 52 Week High
  • FGBI $15.25
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • FGBI 38.91
  • RCEL 41.82
  • Support Level
  • FGBI $8.50
  • RCEL $5.59
  • Resistance Level
  • FGBI $9.18
  • RCEL $6.15
  • Average True Range (ATR)
  • FGBI 0.33
  • RCEL 0.43
  • MACD
  • FGBI -0.04
  • RCEL -0.02
  • Stochastic Oscillator
  • FGBI 0.00
  • RCEL 9.85

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: